Search

Mycobacterium tuberculosis suppresses host antimicrobial peptides by dehydrogenating L-alanine

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 기타
    • 바이오정밀화학
      1. 기타
    • 화장품용 기능성소재
      1. 기타
    • 의료용 화학소재
      1. 식품첨가제
논문

Mycobacterium tuberculosis suppresses host antimicrobial peptides by dehydrogenating L-alanine

학술지

Nature communications

저자명

Peng, Cheng; Cheng, Yuanna; Ma, Mingtong; Chen, Qiu; Duan, Yongjia; Liu, Shanshan; Cheng, Hongyu; Yang, Hua; Huang, Jingping; Bu, Wenyi; Shi, Chenyue; Wu, Xiangyang; Chen, Jianxia; Zheng, Ruijuan; Liu, Zhonghua; Ji, Zhe; Wang, Jie; Huang, Xiaochen; Wang, Peng; Sha, Wei; Ge, Baoxue; Wang, Lin

초록

<P><B>Abstract</B><P>Antimicrobial peptides (AMPs), ancient scavengers of bacteria, are very poorly induced in macrophages infected by <I>Mycobacterium tuberculosis</I> (<I>M. tuberculosis</I>), but the underlying mechanism remains unknown. Here, we report that L-alanine interacts with PRSS1 and unfreezes the inhibitory effect of PRSS1 on the activation of NF-&kappa;B pathway to induce the expression of AMPs, but mycobacterial alanine dehydrogenase (Ald) Rv2780 hydrolyzes L-alanine and reduces the level of L-alanine in macrophages, thereby suppressing the expression of AMPs to facilitate survival of mycobacteria. Mechanistically, PRSS1 associates with TAK1 and disruptes the formation of TAK1/TAB1 complex to inhibit TAK1-mediated activation of NF-&kappa;B pathway, but interaction of L-alanine with PRSS1, disables PRSS1-mediated impairment on TAK1/TAB1 complex formation, thereby triggering the activation of NF-&kappa;B pathway to induce expression of AMPs. Moreover, deletion of antimicrobial peptide gene <I>&beta;-defensin 4</I> (<I>Defb4</I>) impairs the virulence by Rv2780 during infection in mice. Both L-alanine and the Rv2780 inhibitor, GWP-042, exhibits excellent inhibitory activity against <I>M. tuberculosis</I> infection in vivo. Our findings identify a previously unrecognized mechanism that <I>M. tuberculosis</I> uses its own alanine dehydrogenase to suppress host immunity, and provide insights relevant to the development of effective immunomodulators that target <I>M. tuberculosis</I>.</P></P>

발행연도

2024

발행기관

Springer Science and Business Media LLC

ISSN

2041-1723

15

1

페이지

pp.4216

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2024-05-17

Export

About

Search

Trend